China In Vitro Diagnostics Quality Control Market Size & Outlook

The in vitro diagnostics quality control market in China is expected to reach a projected revenue of US$ 87.8 million by 2030. A compound annual growth rate of 3.7% is expected of China in vitro diagnostics quality control market from 2024 to 2030.

Revenue, 2023 (US$M)
$68.3
Forecast, 2030 (US$M)
$87.8
CAGR, 2024 - 2030
3.7%
Report Coverage
China

China in vitro diagnostics quality control market, 2018-2030 (US$M)

China

Related Markets

China in vitro diagnostics quality control market highlights

  • The China in vitro diagnostics quality control market generated a revenue of USD 68.3 million in 2023 and is expected to reach USD 87.8 million by 2030.
  • The China market is expected to grow at a CAGR of 3.7% from 2024 to 2030.
  • In terms of segment, controls was the largest revenue generating product in 2023.
  • Calibrators is the most lucrative product segment registering the fastest growth during the forecast period.


In vitro diagnostics quality control market data book summary

Market revenue in 2023USD 68.3 million
Market revenue in 2030USD 87.8 million
Growth rate3.7% (CAGR from 2023 to 2030)
Largest segmentControls
Fastest growing segmentCalibrators
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationControls, Calibrators
Key market players worldwideSiemens Healthineers AG ADR, Abbott Laboratories, Bio-Rad Laboratories Inc, Danaher Corp, Roche Holding AG ADR, Sysmex Corp, QuidelOrtho Corp, Thermo Fisher Scientific Inc, BD, Merck KGaA, Qiagen NV, Hologic Inc, Bio-Techne Corp, Randox, Helena Laboratories, Seracare Life Sciences, Fortress Diagnostics, Microbiologics, TRINA BIOREACTIVES, Cone Bioproducts, Biorex Food Diagnostics


Other key industry trends

  • In terms of revenue, China accounted for 5.3% of the global in vitro diagnostics quality control market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, China in vitro diagnostics quality control market is projected to lead the regional market in terms of revenue in 2030.
  • India is the fastest growing regional market in Asia Pacific and is projected to reach USD 38.1 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

In Vitro Diagnostics Quality Control Market Scope

In vitro diagnostics quality control market segmentation & scope
Total Protein
Albumin
Blood Urea Nitrogen
Uric Acid
Creatinine
Sodium
Potassium
Chloride
Calcium
Magnesium
Inorganic Phosphorus
Aspartate Transaminase
Creatine Kinase
Gamma Glutamyl transferase
Total Bilirubin
Glucose
Iron
Alanine Transaminase
Alkaline Phosphatase
Alpha Amylase
Total Cholesterol
Triglyceride
Lactate Dehydrogenase
Immunoglobulin G
Immunoglobulin A
Immunoglobulin M
Complement 3
Complement 4
C-Reactive Protein
Rheumatoid Factor
Anti-Streptolysin -O
Beta 2 Micorgloblin
Cystatin-C
Myoglobin
Troponin T and I
Others
Calibrators
Others
Plasma-based Control
Serum-based Control
Whole blood-based Control
Others
Quality Assurance Services
Data Management Solutions
Immunochemistry
Hematology
Alkaline Phosphatase (ALP)
Alanine Transaminase (ALT)
Aspartate Transaminase (AST)
Creatine Kinase MB (CK-MB)
Albumin
Creatinine
Glucose
Triglycerides
Amylase
Others
Molecular Diagnostics
Coagulation
Microbiology
Others
Independent Controls
Instrument Specific Controls
OEM Controls
Hospitals
Laboratories
Home Care
Others

In Vitro Diagnostics Quality Control Market Companies

Name Profile # Employees HQ Website

China in vitro diagnostics quality control market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to in vitro diagnostics quality control market will help companies and investors design strategic landscapes.


Controls was the largest segment with a revenue share of 48.32% in 2023. Horizon Databook has segmented the China in vitro diagnostics quality control market based on controls, calibrators covering the revenue growth of each sub-segment from 2018 to 2030.


The IVD quality control market in China is expected to grow at a lucrative rate during the forecast period. This fast growth can be attributed to the high market potential, advancements in healthcare services, and increasing healthcare expenditure. 

According to a study published by the UK’s NHS, healthcare expenditure in China is projected to reach USD 25.2 billion by 2027, as the country has one of the largest populations in the world. In addition, the prevalence of chronic conditions, such as cancer, cardiovascular diseases, and infectious diseases, is increasing in China. 

These diseases are propelling the demand for improved, technologically advanced, accurate diagnostic tests that can help in the management of these conditions, increasing the need for reliable & accurate laboratory tests. Moreover, key players are undertaking both organic and inorganic growth strategies to gain a competitive edge in China IVD quality control market. 

Reasons to subscribe to China in vitro diagnostics quality control market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of China in vitro diagnostics quality control market databook

  • Our clientele includes a mix of in vitro diagnostics quality control market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the China in vitro diagnostics quality control market , including forecasts for subscribers. This country databook contains high-level insights into China in vitro diagnostics quality control market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

China in vitro diagnostics quality control market size, by product, 2018-2030 (US$M)

China In Vitro Diagnostics Quality Control Market Outlook Share, 2023 & 2030 (US$M)

China in vitro diagnostics quality control market size, by product, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more